Search research articles
Contact Us
Filters
Showing results (401-410 of 440) with videos related to
Page
of 44
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 15, 2018
Response to: The Survival Time of 8376 Male Breast Cancer Patients
B A Wan, V Ganesh, L Zhang, et al.
Elife
|
June 22, 2021
Increased burden of familial-associated early-onset cancer risk among minority Americans compared to non-Latino Whites
Qianxi Feng, Eric Nickels, Ivo S Muskens, et al.
The American Journal of Pathology
|
March 10, 2001
Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium
C Schwesinger, C Yee, R M Rohan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 18, 2024
Chitinase 3-like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPα- and CD24-Siglec10-Mediated Phagocytosis
Bing Ma, Suchitra Kamle, Takayuki Sadanaga, et al.
Genomics
|
February 12, 1998
Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease
A Odermatt, P E Taschner, S W Scherer, et al.
Biochimica Et Biophysica Acta. Biomembranes
|
March 25, 2020
Expansion of the Major Facilitator Superfamily (MFS) to include novel transporters as well as transmembrane-acting enzymes
Steven C Wang, Pauldeen Davejan, Kevin J Hendargo, et al.
The Cancer Journal From Scientific American
|
June 10, 1998
Genetic modification of T-cell clones for therapy of human viral and malignant diseases
P D Greenberg, R J Finch, M A Gavin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2011
American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer
Catherine H Van Poznak, Sarah Temin, Gary C Yee, et al.
The Journal of Biological Chemistry
|
November 9, 2017
An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein
Michael D Glidden, Khadijah Aldabbagh, Nelson B Phillips, et al.
Prenatal Diagnosis
|
May 15, 2009
Screening options for Down syndrome: how women choose in real clinical setting
T K Lo, F K Lai, W C Leung, et al.
Page
of 44
Search research articles
Search
Showing results (401-410 of 440) with videos related to
Sort By:
Page
of 44
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 15, 2018
Response to: The Survival Time of 8376 Male Breast Cancer Patients
B A Wan, V Ganesh, L Zhang, et al.
Elife
|
June 22, 2021
Increased burden of familial-associated early-onset cancer risk among minority Americans compared to non-Latino Whites
Qianxi Feng, Eric Nickels, Ivo S Muskens, et al.
The American Journal of Pathology
|
March 10, 2001
Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium
C Schwesinger, C Yee, R M Rohan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 18, 2024
Chitinase 3-like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPα- and CD24-Siglec10-Mediated Phagocytosis
Bing Ma, Suchitra Kamle, Takayuki Sadanaga, et al.
Genomics
|
February 12, 1998
Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease
A Odermatt, P E Taschner, S W Scherer, et al.
Biochimica Et Biophysica Acta. Biomembranes
|
March 25, 2020
Expansion of the Major Facilitator Superfamily (MFS) to include novel transporters as well as transmembrane-acting enzymes
Steven C Wang, Pauldeen Davejan, Kevin J Hendargo, et al.
The Cancer Journal From Scientific American
|
June 10, 1998
Genetic modification of T-cell clones for therapy of human viral and malignant diseases
P D Greenberg, R J Finch, M A Gavin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2011
American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer
Catherine H Van Poznak, Sarah Temin, Gary C Yee, et al.
The Journal of Biological Chemistry
|
November 9, 2017
An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein
Michael D Glidden, Khadijah Aldabbagh, Nelson B Phillips, et al.
Prenatal Diagnosis
|
May 15, 2009
Screening options for Down syndrome: how women choose in real clinical setting
T K Lo, F K Lai, W C Leung, et al.
Page
of 44